Evaluation of a new connected portable camera for the analysis of skin microrelief and the assessment of the effect of skin moisturisers.

3D skin imaging connected imaging moisturiser nomadic imaging roughness skin microrelief skin pattern

Journal

Skin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging (ISSI)
ISSN: 1600-0846
Titre abrégé: Skin Res Technol
Pays: England
ID NLM: 9504453

Informations de publication

Date de publication:
Jan 2023
Historique:
received: 12 11 2021
accepted: 19 06 2022
pubmed: 22 12 2022
medline: 31 1 2023
entrez: 21 12 2022
Statut: ppublish

Résumé

Silicone replicas and non-contact methods are effective methods to analyse the micrometric scale of the skin microrelief. Yet, they imply data capture in research facilities. The capabilities of a new connected portable camera were evaluated to analyse microrelief under nomadic conditions, also studying the effect of moisturisers. 3D depth maps were constructed using shape-from-shading algorithms. Roughness heterogeneity (Spa) was computed, and skin profiles were extracted to calculate roughness amplitude (Ra, Rq), as well as furrows/plateaus characteristics. Validation of the connected camera was performed on tanned cowhide leather and on the inner forearm skin of a single subject. The forearms of 18 subjects (23-60 years old) were also evaluated. While living their regular life, they self-performed triplicate acquisitions at various times. The effects of a placebo and of cream containing moisturisers-saccharide isomerate, urea or xylitylglucoside-anhydroxylitol-xylitol-were investigated, using untreated control skin as a reference. Validation of the device on leather and forearm skin shows high repeatability. The 18 subjects show the known correlation between age and changes in microrelief. While testing formulas, 8 h after a single application, all decreased Spa (-1.6/-2.1 folds). Only saccharide isomerate and xylitylglucoside-anhydroxylitol-xylitol decreased Ra (-2.4/-2.8 folds). The sectional area of plateaus was reduced from -1.5 (urea) to -2.1 folds (xylitylglucoside-anhydroxylitol-xylitol). The height of plateaus is also decreased by all moisturisers, from -1.5 (urea) to -2.1 folds (xylitylglucoside-anhydroxylitol-xylitol). This novel camera device enables microrelief analysis under nomadic conditions, allowing monitoring its changes along the day and upon moisturisers' application.

Sections du résumé

BACKGROUND BACKGROUND
Silicone replicas and non-contact methods are effective methods to analyse the micrometric scale of the skin microrelief. Yet, they imply data capture in research facilities. The capabilities of a new connected portable camera were evaluated to analyse microrelief under nomadic conditions, also studying the effect of moisturisers.
MATERIALS AND METHODS METHODS
3D depth maps were constructed using shape-from-shading algorithms. Roughness heterogeneity (Spa) was computed, and skin profiles were extracted to calculate roughness amplitude (Ra, Rq), as well as furrows/plateaus characteristics. Validation of the connected camera was performed on tanned cowhide leather and on the inner forearm skin of a single subject. The forearms of 18 subjects (23-60 years old) were also evaluated. While living their regular life, they self-performed triplicate acquisitions at various times. The effects of a placebo and of cream containing moisturisers-saccharide isomerate, urea or xylitylglucoside-anhydroxylitol-xylitol-were investigated, using untreated control skin as a reference.
RESULTS RESULTS
Validation of the device on leather and forearm skin shows high repeatability. The 18 subjects show the known correlation between age and changes in microrelief. While testing formulas, 8 h after a single application, all decreased Spa (-1.6/-2.1 folds). Only saccharide isomerate and xylitylglucoside-anhydroxylitol-xylitol decreased Ra (-2.4/-2.8 folds). The sectional area of plateaus was reduced from -1.5 (urea) to -2.1 folds (xylitylglucoside-anhydroxylitol-xylitol). The height of plateaus is also decreased by all moisturisers, from -1.5 (urea) to -2.1 folds (xylitylglucoside-anhydroxylitol-xylitol).
CONCLUSION CONCLUSIONS
This novel camera device enables microrelief analysis under nomadic conditions, allowing monitoring its changes along the day and upon moisturisers' application.

Identifiants

pubmed: 36541033
doi: 10.1111/srt.13190
pmc: PMC9838641
doi:

Substances chimiques

Xylitol VCQ006KQ1E
Emollients 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e13190

Subventions

Organisme : Newtone Technologies and Seppic

Informations de copyright

© 2022 Newtone Technologies and The Authors. Skin Research and Technology published by John Wiley & Sons Ltd.

Références

J Invest Dermatol. 2001 Sep;117(3):718-24
pubmed: 11564182
Int J Mol Sci. 2016 May 24;17(6):
pubmed: 27231897
J Invest Dermatol. 2014 Jun;134(6):1636-1644
pubmed: 24418925
J Cosmet Dermatol. 2018 Apr;17(2):138-144
pubmed: 29319217
Maedica (Bucur). 2014 Mar;9(1):33-8
pubmed: 25553123
Photodermatol. 1988 Apr;5(2):92-5
pubmed: 3399440
Skin Res Technol. 2010 Aug;16(3):270-4
pubmed: 20636994
Pediatr Dermatol. 2010 Mar-Apr;27(2):125-31
pubmed: 19804498
Skin Res Technol. 2018 Aug;24(3):359-366
pubmed: 29368349
Chronobiol Int. 1996 Aug;13(3):199-211
pubmed: 8874983
Skin Res Technol. 2015 Feb;21(1):69-75
pubmed: 24889351
J Biol Rhythms. 2015 Jun;30(3):163-82
pubmed: 25589491
Contact Dermatitis. 1998 Nov;39(5):227-30
pubmed: 9840258
Dermatol Ther. 2018 Nov;31(6):e12690
pubmed: 30378232
Skin Res Technol. 2003 Nov;9(4):343-7
pubmed: 14641885
Skin Res Technol. 1995 Aug;1(3):109-14
pubmed: 27328437
Br J Dermatol. 2002 Oct;147(4):689-95
pubmed: 12366414
Skin Res Technol. 2002 Nov;8(4):212-8
pubmed: 12423539
Skin Res Technol. 2014 Aug;20(3):299-306
pubmed: 24267349
Arch Dermatol. 1964 Feb;89:267-73
pubmed: 14081572
Skin Res Technol. 2019 Mar;25(2):165-170
pubmed: 30345616
J Am Acad Dermatol. 1986 Oct;15(4 Pt 1):571-85
pubmed: 3534008
Int J Cosmet Sci. 1980 Aug;2(4):209-14
pubmed: 19467094
Skin Res Technol. 2013 May;19(2):84-90
pubmed: 23279017
Arch Dermatol Res. 2000 Oct;292(10):500-10
pubmed: 11142772
Biointerphases. 2016 Sep 15;11(3):031015
pubmed: 27634368
J Gerontol. 1980 May;35(3):348-54
pubmed: 7410785
Skin Res Technol. 2023 Jan;29(1):e13190
pubmed: 36541033
Int J Cosmet Sci. 2006 Dec;28(6):389-95
pubmed: 18489285
Clin Med Res. 2017 Dec;15(3-4):75-87
pubmed: 29229630
J Clin Aesthet Dermatol. 2019 Sep;12(9):42-45
pubmed: 31641418
Am J Dermatopathol. 1987 Dec;9(6):500-9
pubmed: 3445927
J Invest Dermatol. 1998 Jan;110(1):20-3
pubmed: 9424081
Skin Pharmacol Appl Skin Physiol. 1999 Jan-Apr;12(1-2):1-11
pubmed: 10325578
Skin Pharmacol Appl Skin Physiol. 1999 Nov-Dec;12(6):352-62
pubmed: 10545832
Int J Dermatol. 1974 Nov-Dec;13(6):357-81
pubmed: 4214793
Dermatology. 1998;196(4):401-7
pubmed: 9669115
Skin Res Technol. 2004 Nov;10(4):207-14
pubmed: 15479444
IEEE Trans Pattern Anal Mach Intell. 2005 Aug;27(8):1254-64
pubmed: 16119264
Adv Exp Med Biol. 1999;455:507-16
pubmed: 10599390
Arch Dermatol Res. 2006 Mar;297(9):412-6
pubmed: 16328340
Skin Res Technol. 2011 Feb;17(1):51-5
pubmed: 20923460
Skin Res Technol. 2005 May;11(2):110-9
pubmed: 15807809

Auteurs

Sarah Gougeon (S)

Newtone Technologies, Lyon, France.

Elsa Hernandez (E)

Seppic, Paris, France.

Nathalie Chevrot (N)

Seppic, Paris, France.

Thibault Vergne (T)

Newtone Technologies, Lyon, France.

Marie Cherel (M)

Newtone Technologies, Lyon, France.

Elodie Prestat-Marquis (E)

Newtone Technologies, Lyon, France.

Matthieu Jomier (M)

Newtone Technologies, Lyon, France.

Elodie Burty-Valin (E)

Seppic, Paris, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH